Differential functional genomic effects of anti-inflammatory phytocompounds on immune signaling

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Chiu, Shao Chih ^a,b   Tsao, Shan Wen ^c   Hwang, Pei Ing ^e   Vanisree, Staniforth ^c   Chen, Yi An ^e   Yang, Ning Sun ^c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^d NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^e INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BIDENS PILOSA EXTRACT; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CYTOPILOYNE; ECHINACEA EXTRACT; EMODIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 8 RECEPTOR; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCYTE CHEMOTACTIC PROTEIN 2; NUCLEIC ACID BINDING PROTEIN; PROTEIN BCL 2; PROTEIN E6; PROTEIN RAD23A; SHIKONIN; STAT1 PROTEIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; GLUCOSIDE; NAPHTHOQUINONE; PLANT EXTRACT; POLYACETYLENE DERIVATIVE;

ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL VIABILITY; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DNA MICROARRAY; DOWN REGULATION; ENZYME ACTIVATION; FUNCTIONAL GENOMICS; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MICROARRAY ANALYSIS; MONOCYTE; PHYTOCHEMISTRY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL DEATH; CELL LINE; CHEMISTRY; CLUSTER ANALYSIS; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; IMMUNITY; IMMUNOLOGY; KINETICS; METHODOLOGY; REGULATOR GENE;

ANTI-INFLAMMATORY AGENTS; CELL DEATH; CELL LINE; CLUSTER ANALYSIS; EMODIN; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, SWITCH; GENOMICS; GLUCOSIDES; HUMANS; IMMUNITY; KINETICS; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MONOCYTES; NAPHTHOQUINONES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLANT EXTRACTS; POLYACETYLENES; SIGNAL TRANSDUCTION;

EID: 77956909628     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-513     Document Type: Article

References (40)

1. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501. 10.1016/S0092-8674(01)00237-9, 11239407.
2. Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216. 10.1146/annurev.immunol.20.083001.084359, 11861602.
3. Sharif O, Bolshakov VN, Raines S, Newham P, Perkins ND. Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immuno 2007, 8:1.
4. Harkonen PL, Vaananen HK. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. Ann N Y Acad Sci 2006, 1089:218-227. 10.1196/annals.1386.045, 17261769.
5. Nilsson R, Bajic VB, Suzuki H, di Bernardo D, Björkegren J, Katayama S, Reid JF, Sweet MJ, Gariboldi M, Carninci P, Hayashizaki Y, Hume DA, Tegner J, Ravasi T. Transcriptional network dynamics in macrophage activation. Genomics 2006, 88:133-42. 10.1016/j.ygeno.2006.03.022, 16698233.
6. Staniforth V, Wang SY, Shyur LF, Yang NS. Shikonins, phytocompounds from Lithospermum erythrorhizon, inhibit the transcriptional activation of human tumor necrosis factor alpha promoter in vivo. J Biol Chem 2004, 279:5877-5885. 10.1074/jbc.M309185200, 14645256.
7. Song E, Antus B, Yao Y, Lutz J, Heemann U. Sequential activation patterns of macrophages in chronic allograft nephropathy. Graft 2002, 5:141-144.
8. Russell SW, Doe WF, McIntosh AT. Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors. J Exp Med 1977, 146:1511-1520. 10.1084/jem.146.6.1511, 2181899, 925611.
9. Chiu SC, Yang NS. Inhibition of tumor necrosis factor-alpha through selective blockade of pre-mRNA splicing by shikonin. Mol Pharmaco 2007, 51:1506-1512.
10. Chen RF, Shen YC, Huang HS, Liao JF, Ho LK, Chou YC, Wang WY, Chen CF. Evaluation of the anti-inflammatory and cytotoxic effects of anthraquinones and anthracene derivatives in human leucocytes. J Pharm Pharmacol 2004, 56:915-919. 10.1211/0022357023781, 15233871.
11. Li HL, Chen HL, Li H, Zhang KL, Chen XY, Wang XW, Kong QY, Liu J. Regulatory effects of emodin on NF-kappaB activation and inflammatory cytokine expression in RAW 264.7 macrophages. Int J Mol Med 2005, 16:41-47.
12. Chiang YM, Chang CL, Chang SL, Yang WC, Shyur LF. Cytopiloyne, a novel polyacetylenic glucoside from Bidens pilosa, functions as a T helper cell modulator. J Ethnopharmacol 2007, 110:532-8. 10.1016/j.jep.2006.10.007, 17101254.
13. Chang CL, Chang SL, Lee YM, Chiang YM, Chuang DY, Kuo HK, Yang WC. Cytopiloyne, a polyacetylenic glucoside, prevents Type 1 diabetes in nonobese diabetic mice. J Immunol 2007, 178:6984-6993.
14. Wang CY, Chiao MT, Yen PJ, Huang WC, Hou CC, Chien SC, Yeh KC, Yang WC, Shyur LF, Yang NS. Modulatory effects of Echinacea purpurea extracts on human dendritic cells: a cell- and gene-based study. Genomics 2006, 88:801-808. 10.1016/j.ygeno.2006.08.011, 17011161.
15. Harrison LM, van den Hoogen C, van Haaften WC, Tesh VL. Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides. Infect Immun 2005, 73:403-412. 10.1128/IAI.73.1.403-412.2005, 538957, 15618178.
16. Mikita T, Porter G, Lawn RM, Shiffman D. Oxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus. J Biol Chem 2001, 276:45729-45739. 10.1074/jbc.M106114200, 11577090.
17. Yang S, Tamai R, Akashi S, Takeuchi O, Akira S, Sugawara S, Takada H. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect Immun 2001, 69:2045-2053. 10.1128/IAI.69.4.2045-2053.2001, 98129, 11254557.
18. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003, 3:169-176. 10.1038/nri1004, 12563300.
19. Le Naour F, Hohenkirk L, Grolleau A, Misek DE, Lescure P, Geiger JD, Hanash S, Beretta L. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J Biol Chem 2001, 276:17920-17931. 10.1074/jbc.M100156200, 11279020.
20. Wang CY, Staniforth V, Chiao MT, Hou CC, Wu HM, Yeh KC, Chen CH, Hwang PI, Wen TN, Shyur LF, Yang NS. Genomics and proteomics of immune modulatory effects of a butanol fraction of Echinacea purpurea in human dendritic cells. BMC Genomics 2008, 9:479. 10.1186/1471-2164-9-479, 2571112, 18847511.
21. Krull M, Pistor S, Voss N, Kel A, Reuter I, Kronenberg D, Michael H, Schwarzer K, Potapov A, Choi C, Kel-Margoulis O, Wingender E. TRANSPATH: an information resource for storing and visualizing signaling pathways and their pathological aberrations. Nucleic Acids Res 2006, (34 Database):D546-D551. 10.1093/nar/gkj107, 1347469, 16381929.
22. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. Activation of IKK by TNF-α requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 2006, 22:245-257. 10.1016/j.molcel.2006.03.026, 16603398.
23. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF, . Inflammation and Host Response to Injury Large Scale Collab Res Program A network-based analysis of systemic inflammation in humans. Nature 2005, 437:1032-1037. 10.1038/nature03985, 16136080, Inflammation and Host Response to Injury Large Scale Collab Res Program.
24. Holter W, Goldman CK, Casabo L, Nelson DL, Greene WC, Waldmann TA. Expression of functional IL 2 receptors by lipopolysaccharide and interferon-g stimulated human monocytes. J Immunol 1987, 138:2917-2922.
25. Holter W, Grunow R, Stockinger H, Knapp W. Recombinant interferon-g induces interleukin 2 receptors on human peripheral blood monocytes. J Immunol 1986, 136:2171-2175.
26. Wahl SM, McCartney-Francis N, Hunt DA, Smith PD, Wahl LM, Katona IM. Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity. J Immunol 1987, 139:1342-1347.
27. Tchou-Wong KM, Tanabe O, Chi C, Yie TA, Rom WN. Activation of NF-kappaB in Mycobacterium tuberculosis- induced interleukin-2 receptor expression in mononuclear phagocytes. Am J Respir Crit Care Med 1999, 159:1323-1329.
28. Chen X, Yang L, Oppenheim JJ, Howard MZ. Cellular pharmacology studies of shikonin derivatives. Phytother Res 2002, 16:199-209. 10.1002/ptr.1100, 12164262.
29. Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev 2004, 18:2195-2224. 10.1101/gad.1228704, 15371334.
30. Wullaert A, Heyninck K, Janssens S, Beyaert R. Ubiquitin: tool and target for intracellular NF-kappaB inhibitors. Trends Immunol 2006, 27:533-540. 10.1016/j.it.2006.09.003, 16982211.
31. Wang JH, Lin KF, Benson SA, Sun SJ, Cheng WM, Wang SY, Shyur LF, Yang NS. Tissue array transgene expression system for the evaluation of effect of medicinal herbs on wound-healing. J Gen Mol Biol 2003, 14:133-144.
32. Dumitru CD, Ceci JD, Tsatsanis C, Kontoyiannis D, Stamatakis K, Lin JH, Patriotis C, Jenkins NA, Copeland NG, Kollias G, Tsichlis PN. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 2000, 103:1071-1083. 10.1016/S0092-8674(00)00210-5, 11163183.
33. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvalsa J, Clark AR. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor mRNA stability. Mol Cell Biol 2001, 21:6461-6469. 10.1128/MCB.21.9.6461-6469.2001, 99793, 11533235.
34. Jeffrey KL, Camps M, Rommel C, Mackay CR. Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 2007, 6:391-403. 10.1038/nrd2289, 17473844.
35. Lang R, Hammer M, Mages J. DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol 2006, 177:7497-7504.
36. Berenson LS, Yang J, Sleckman BP, Murphy TL, Murphy KM. Selective requirement of p38α MAPK in cytokine-dependent, but not antigen receptor-dependent, TH1 responses. J Immunol 2006, 176:4616-4621.
37. Rincon M, Flavell RA, Davis RA. The JNK and p38 MAP kinase signaling pathways in T cell-mediated immune responses. Free Radic Biol Med 2000, 28:1328-1337. 10.1016/S0891-5849(00)00219-7, 10924852.
38. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO. The transcriptional program in the response of human fibroblasts to serum. Science 1999, 283:83-87. 10.1126/science.283.5398.83, 9872747.
39. Yang NS, Shyur LF, Chen CH, Wang SY, Tzeng CM. Medicinal herb extract and a single-compound drug confer similar complex pharmacogenomic activities in mcf-7 cells. J Biomed Sci 2004, 11:418-422. 10.1007/BF02254447, 15067226.
40. Jaeger J, Spang R. Selecting normalization genes for small diagnostic microarrays. BMC Bioinformatics 2006, 7:388. 10.1186/1471-2105-7-388, 1560169, 16925821.